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372Erythrocyte Sedimentation Rate as Baseline
Predictor for the Development of Uveitis in
Children With Juvenile Idiopathic ArthritisARENDA J.W. HAASNOOT, MARETTA VAN TENT-HOEVE, NICO M. WULFFRAAT,
NICOLINE E. SCHALIJ-DELFOS, LEONOOR I. LOS, WINEKE ARMBRUST, NICOLAAS P.A. ZUITHOFF, AND
JOKE H. DE BOER PURPOSE: To analyze inflammatory parameters as
possible predictors for the development of uveitis in juve-
nile idiopathic arthritis (JIA) patients. Further, to analyze
the predictive value of demographic and clinical factors at
the onset of arthritis.
 DESIGN: Retrospective cohort study.
 METHODS: In 358 children with oligoarthritis and
rheumatoid factor–negative polyarthritis, erythrocyte
sedimentation rate (ESR), C-reactive protein, leukocyte
count, presence of antinuclear antibodies (ANA), pres-
ence of human leukocyte antigen (HLA-)B27, age of
onset of JIA, and sex were analyzed for their predictive
value for the onset of uveitis.
 RESULTS: One hundred forty-seven patients (41%)
were diagnosed with chronic anterior uveitis. Young age
of onset, presence of ANA, and elevated ESR appeared
to be predictive factors according to univariate analyses
(P[ .029, P[ .007, and P[ 5EL4, respectively). Ac-
cording to multivariate analysis, young age of onset and
elevated ESR appeared to be predictive after adjusting
for the other relevant factors (P[ .004 and P[ .001,
respectively). A prediction model was developed.
 CONCLUSIONS: Elevated ESR appears to be a predictor
for the occurrence of uveitis in patients with JIA. Since
ESR is already routinely tested in patients with recently
diagnosed arthritis, its use as a biomarker can easily
be implemented in daily practice. (Am J Ophthalmol
2015;159:372–377.  2015 by Elsevier Inc. All rights
reserved.)r publication Nov 4, 2014.
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UVENILE IDIOPATHIC ARTHRITIS (JIA) IS THE MOST
common rheumatic disease in childhood and is defined
as arthritis without a known etiology that begins prior
to the age of 16 and persists for at least 6 weeks.1,2
Uveitis, typically chronic anterior uveitis, is the most
common extra-articular manifestation in patients with
JIA and JIA is the most common systemic association of
uveitis in children.3,4 The JIA subtype with the highest
association with uveitis is oligoarthritis, followed by
rheumatoid factor (RF)-negative polyarthritis, with an
incidence of 13%–45% and 10%, respectively.4,5
The severity of uveitis at presentation is known to pre-
dict a severe course and worse visual outcome.6 Since the
course of chronic anterior uveitis is asymptomatic, routine
ophthalmologic examination is required in patients with
JIA and early treatment is critical to prevent visual loss.6
Despite early detection, aggressive autoimmune disease
can cause harmful uveitis with a worse outcome as well.
Complications associated with poorly controlled or un-
treated uveitis include posterior synechiae, cataract, glau-
coma, cystoid macular edema, and band keratopathy.6–8
Among patients with JIA, the oligoarticular subtype,
antinuclear antibodies (ANA) positivity, young age of
onset, and female sex in early-onset arthritis are predictive
factors for the development of uveitis.4,9–12 Identification
of more predictors can help to improve screening
protocols for routine examination in order to focus even
more on those with the highest risk and to protect them
from visual loss.
The aim of this study is to analyze inflammatory param-
eters and demographic and clinical factors at the onset of
arthritis as possible predictors for the development of uve-
itis among patients with JIA.PATIENTS AND METHODS
A RETROSPECTIVE COHORT STUDY OF 358 PATIENTS WITH
JIA visiting the ophthalmologist or the pediatric rheuma-
tologist at the University Medical Center of Utrecht,
Leiden and Groningen in the Netherlands was performed.
Only patients with the JIA subtypes oligoarthritis and RF-
negative polyarthritis were included. The JIA diagnosis0002-9394/$36.00
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based on the criteria of the International League of Associ-
ations for Rheumatology was confirmed by a pediatric rheu-
matologist and all patients with JIA were screened by an
ophthalmologist at least as many times as recommended
by the guidelines of the American Academy of Pediat-
rics.2,13,14 Patients with onset of uveitis before arthritis
were excluded. Also, patients with uveitis entities other
than chronic anterior uveitis were excluded. Patients
were divided into 2 groups: JIA patients with (Group 1)
and without (Group 2) uveitis. The patients in the
second group had an ophthalmologic follow-up of at least
4 years without signs of uveitis. The collection of data
from patients’ medical charts for the research goals as
described in this article was approved by the Institutional
Review Board of the Utrecht University Medical Center
and is in compliance with the Helsinki principles.
The values of the inflammatory parameters erythrocyte
sedimentation rate (ESR), C-reactive protein (CRP), and
leukocyte count at the time of diagnosis of JIA were
collected from patients’ medical charts. Only results of pa-
tients with inflammatory parameters tested 12 months or
less prior to the diagnosis of JIA, 12 months or less after
diagnosis of JIA, and before the start of systemic immuno-
suppressive therapy were included in the analyses. Informa-
tion about the presence of ANA at the time of diagnosis of
JIA was collected. Additional patient characteristics
including date of birth, sex, date of onset of JIA, date of
onset of uveitis, and presence of human leukocyte antigen
(HLA-)B27 were collected from the medical charts. The
age of onset of JIA was calculated from the date of birth
and date of onset of JIA. The date of onset of JIA and
the date of onset of uveitis were used to calculate the
time interval between JIA and uveitis.
In some medical charts it was unclear whether the pa-
tient had ever been diagnosed with uveitis. Therefore, a
questionnaire was sent to 42 patients with JIA, who
were screened by an ophthalmologist outside the Univer-
sity Medical Centers. Three patients confirmed the uve-
itis diagnosis; these patients or their parents were asked
to sign an informed consent in order to make a copy of
the ophthalmologist’s patient’s medical chart available.
This chart was additionally checked for the presence of
uveitis, to be sure all patients would be placed in the cor-
rect group (uveitis vs non-uveitis). The collected addi-
tional information of all these 42 patients was obtained
from the medical charts of the University Medical
Centers.
Statistical analyses were performed with IBM SPSS
Statistics version 20 for Windows and the R rms package.
Univariate analyses were performed to find independent
predictors that might enter the multivariate analysis. The
Pearson x2 test or Fisher exact test was applied for univar-
iate analysis of categorical variables. Since there were
no normally distributed variables, confirmed by the
Kolmogorov-Smirnov-test, the Mann-Whitney U test
was used for continuous, abnormally distributed variables.VOL. 159, NO. 2 PREDICTORS FOR UVEITIS IN JUVSubgroup analyses were performed for patients with RF-
negative polyarthritis and oligoarthritis. Statistically signif-
icant variables in univariate analysis as well as previously
known predictors were selected for multivariate analysis
by logistic regression. The continuous variable age of onset
of JIA was dichotomized according to clinical standards
based on prior literature with an age of 6 years as a cutoff
point.14 P values <_.05 were regarded as statistically signifi-
cant. For presentation, medians were used for the abnor-
mally distributed variables. Based on the results of the
multivariate analysis and the current screening guidelines
for uveitis in patients with JIA (which includes ANA
and age of onset of JIA), a prediction model was devel-
oped.4,14 To test the ability to discriminate between
patients with and without uveitis, the area under the
receiver operating characteristic curve was determined.
When prediction models are derived from multivariate
regression analyses, overestimation of regression
coefficients is a known phenomenon that results in too
extreme predictions in new patients. Therefore, internal
validation with bootstrapping techniques was applied,
which resulted in a shrinkage factor for the regression coef-
ficients.15 Also, the value for the area under the receiver
operating characteristic curve was corrected for optimism
using the bootstrap procedure.RESULTS
 GENERAL CHARACTERISTICS OF STUDY POPULATION:
From a total of 358 patients with oligoarthritis and RF-
negative polyarthritis entering the study, 147 (41%)
were diagnosed with chronic anterior uveitis. All of these
patients had at least 1þ cells in the anterior chamber at
consecutive visits that needed treatment with topical ste-
roids or immunomodulating medication.16 The median
time between JIA onset and uveitis onset was 1.0 year
(range 0.0–24.3 years). Fifty percent of the patients
developed uveitis within the first year after onset of
JIA, 66% did so within the first 2 years, and in 85% uveitis
occurred within the first 4 years. In the majority of the pa-
tients the inflammatory parameters were tested at the
moment of JIA diagnosis (median time between diagnosis
of JIA and laboratory records: 0 months, interquartile
range: 0–0 months). The proportion of subtypes of JIA
in the group of patients with uveitis could be compared
to that in the group of patients without uveitis, with
oligoarthritis being the most common subtype. Likewise,
the female-to-male ratio was similar in both groups
(Table 1).
 AGEOFONSET: The median age of onset of JIA appeared
to be statistically different between the 2 groups. The me-
dian age was 2.7 years in patients with uveitis and 3.1 years
in patients without uveitis (P ¼ .029).373ENILE IDIOPATHIC ARTHRITIS
TABLE 1. Demographic and Clinical Data of Patients With
Juvenile Idiopathic Arthritis Grouped According to the
Occurrence of Uveitis
Uveitis Non-Uveitis P Value
Sex, no. (%)
No. patients 147 211 .394a
Female 112 (76) 151 (72)
Male 35 (24) 60 (28)
JIA subtype, no. (%)
No. patients 147 211 .282b
Oligoarthritis 108 (74) 141 (67)
Polyarthritis 39 (26) 70 (33)
Age (y) of onset JIA
No. patients 148 213
Median (range) 2.7 (0.9–9.5) 3.1 (0.7–15.0) .029c,d
ANA, no. (%)
No. patients 146 211
Positive 113 (77) 135 (64) .007a,d
Negative 33 (23) 76 (36)
HLA-B27, no. (%)
No. patients 54 73
Positive 9 (17) 11 (15) .811a
Negative 45 (83) 62 (85)
ESR (mm)
No. patients 112 197
Median (range) 32 (2–150) 23 (2–115) 5E4,d
CRP (mg/L)
No. patients 105 188
Median (range) 11.0 (0–136) 6.0 (0–303) .053c
Leukocyte
count 3 109/L
No. patients 108 195
Median (range) 9.4 (4.5–109) 9.32 (3.8–18.9) .749c
ANA ¼ antinuclear antibodies; CRP ¼ C-reactive protein;
ESR ¼ erythrocyte sedimentation rate; HLA-B27 ¼ human
leukocyte antigen B27; JIA ¼ juvenile idiopathic arthritis.
aFisher exact test.
bPearson x2.
cMann-Whitney U test.
dSignificant P values. ANTINUCLEAR ANTIBODIES AND HUMAN LEUKOCYTE
ANTIGEN B27: Patients with uveitis were significantly
more often ANA-positive compared to patients without
uveitis (P ¼ .007). Presence of HLA-B27 did not entail a
significant difference between the 2 groups.
 INFLAMMATORYPARAMETERS: Statistically, ESR at the
time of diagnosis of JIA was significantly more elevated in
the uveitis group (median 32 mm) compared to the non-
uveitis group (median 23 mm; P ¼ 5E4; Table 1). Also,
in the oligoarticular and polyarticular subgroups, ESR was
significantly more elevated in patients with uveitis. In pa-
tients with oligoarthritis, the median value was 30 mm in
patients with uveitis and 20 mm in patients without uveitis374 AMERICAN JOURNAL OF(P¼ .008). In patients with polyarthritis, the median value
was 40 mm in patients with uveitis and 27 mm in patients
without uveitis (P¼ .010). After analyzing ESR exclusively
in patients who developed uveitis in the first year after
onset of JIA, there appeared to be a strong statistical differ-
ence between the ESR in the 2 groups with 39 mm in the
uveitis group and 23 mm in the non-uveitis group (P ¼
1.7E5, uveitis n¼ 55, non-uveitis n¼ 197). In the second
(n¼ 18, ESR¼ 30mm), third (n¼ 10, ESR¼ 26mm), and
fourth (n ¼ 11, ESR ¼ 19 mm) year after JIA diagnosis,
ESR was slightly elevated in the second and third year in
the uveitis group. In these 3 groups there was no statisti-
cally significant difference compared to the non-uveitis
(n ¼ 197, ESR ¼ 23 mm) group (P ¼ .318, P ¼ .839,
and P ¼ .493, respectively). The inflammatory parameters
CRP and leukocyte count at the time of diagnosis of JIA did
not statistically differ between the 2 groups (Table 1).
 MULTIVARIATE ANALYSIS AND PREDICTION MODEL:
Because of the statistically significant outcomes in univar-
iate analysis, ANA, age of onset of JIA, and ESR were
selected for multivariate analysis. Additionally, the factors
sex and JIA subtype were selected. Adjusted for age of onset
of JIA, ANA, sex, and JIA subtype, ESR appeared to be a
statistically significant predictor for the occurrence of uve-
itis in patients with JIA with an odds ratio (OR) of 1.016
(95% confidence interval [CI] 1.006–1.026, P ¼ .001),
which means that for each elevation of 1 mm ESR, the
odds for the occurrence of uveitis increase by 0.016
(Table 2). Onset of JIA before the age of 7 years was,
adjusted for ANA, ESR, sex, and JIA subtype, a statistically
significant predictive factor for the occurrence of uveitis in
patients with JIA with an OR of 3.167 (95% CI 1.432–
7.006, P ¼ .004; Table 2). The predictors ANA, age of
onset, and ESR were included in the prediction model
(Figure 1). The area under the receiver operating charac-
teristic curve of the model was 0.644 (95% CI: 0.582–
0.706; Figure 2).DISCUSSION
FOR THE IMPROVEMENT OF OUR KNOWLEDGE OF THE
occurrence of uveitis in JIA patients the identification of
predictors remains important. In this study we examined
the predictive value of the inflammatory parameters ESR,
CRP, and leukocyte count. We found an elevated ESR at
the time of diagnosis of JIA to be predictive for the occur-
rence of uveitis in patients with JIA according to univariate
analysis. Four previous studies examined the relationship
between ESR and the occurrence of uveitis in patients
with JIA.4,10,17,18 Elevated ESR appeared to be predictive
in 3 of these previous retrospective studies as well.
Statistically, these studies found significantly more
elevated ESR values of >_35 mm in patients with uveitisFEBRUARY 2015OPHTHALMOLOGY
TABLE 2. Risk for the Occurrence of Uveitis in Children With
Juvenile Idiopathic Arthritis According to Multivariate
Analysis by Logistic Regression (Uveitis n ¼ 112;
Non-uveitis n ¼ 197)
ORa (95% CIb) P Value
Female sex 0.995 (0.561–1.764) .986
Oligoarticular subtype 1.406 (0.817–2.419) .219
Age of onset JIA <_ 6 years 3.167 (1.432–7.006) .004d
ANA positivity 1.397 (0.813–2.402) .226
ESR 1.016c (1.006–1.026) .001d
ANA¼ antinuclear antibodies; CI¼ confidence interval; ESR¼
erythrocyte sedimentation rate; JIA¼ juvenile idiopathic arthritis;
OR ¼ odds ratio.
aOdds ratios for dichotomous variables: the greater the OR,
the higher the risk for the occurrence of uveitis.
bConfidence interval is the interval estimate of the odds ratio.
cOdds ratio for ESR: for every elevation of 1 ESR-point, the
odds for the occurrence of uveitis increase by 0.016.
dSignificant P values.
FIGURE 1. Prediction model to predict the risk for the occur-
rence of uveitis in patients with juvenile idiopathic arthritis.
ANA[ antinuclear antibodies; ESR[ erythrocyte sedimenta-
tion rate; £6 years[ age of onset of juvenile idiopathic arthritis
(JIA) is 6 or below the age of 6 years;>6 years[ age of onset
of JIA is above 6 years. The risk for the occurrence of uveitis
based on ANA, age of onset of JIA, and ESR at time of diagnosis
of JIA is calculated with the formula [ ex/(1 D ex), with
x [ L2.171 D (0.305 3 ANA) D (1.126 3 age of
onset)D (0.0143 ESR). The regression coefficients in this for-
mula are derived from multivariate logistic regression with addi-
tion of the bootstrapping technique. Example of a case: A patient
presents with JIA. He/she is 3 years old and has a negative ANA
in the laboratory and an ESR of 50 mm. This patient has a
predicted risk to develop uveitis of 0.41.compared to ESR values of <_35 mm in patients without
uveitis. Our outcomes are perfectly in concordance with
these previous studies. Additionally we found ESR to be
a predictor in multivariate analysis. This is the second
study demonstrating an elevated ESR to be predictive
after adjusting for other predictors in a larger study
population.18 One study described ESR as not having a sig-
nificant influence on the occurrence of uveitis according to
multivariate analysis.4 Patients diagnosed with uveitis prior
to the onset of JIA were not excluded from this study,
which might explain this contrasting outcome.
In the groups that developed uveitis 2 years and 3 years
after JIA onset, ESR was more elevated in uveitis as
compared to non-uveitis patients, but the difference
was not statistically significant. The lack of a statistical
difference can be explained by the lack of power because
only 18 and 10 uveitis patients, respectively, were
included in these specific groups. In the group devel-
oping uveitis 4 years after JIA onset, ESR values were
comparable for both groups. ESR in the course of JIA is
dependent on many factors, including autoimmune dis-
ease activity and treatment with immunomodulating
medication. In some of our patients with normal ESR
at JIA onset, uveitis debuted 4 years later and several
months after methotrexate was stopped. So uveitis might
have been suppressed by immunosuppressive therapy and
in a few other cases, late uveitis onset was related to JIA
flare-up.
The exact mechanism of JIA uveitis and the immunopa-
thogenic link between JIA and uveitis is still unknown, but it
is considered to be a multifactorial autoimmune disease.19,20
In general, elevated ESR values indicate more activity of the
autoimmune disease, so elevated ESR in uveitis patients
might reflect a more activated state of the immune system.VOL. 159, NO. 2 PREDICTORS FOR UVEITIS IN JUVThis might enhance influx of inflammatory cells in the eye
with probably a dysbalance of T-helper cells and T-
regulatory cells resulting in uveitis. However, more
research is warranted to clarify the pathogenesis of uveitis
in JIA and the relation with JIA activity.
According to our knowledge, the predictive value of
CRP has been tested twice before. In 1 study CRP was
dichotomized with a cutoff value of 5 mg/L; based on their
laboratory standards, a CRP of >5 mg/L did not appear to
be predictive for the occurrence of uveitis.10 The other
study did not find a difference between the mean CRPs.18
We confirmed these outcomes and did not find CRP to
be predictive in our series. However, we cannot rule out
that it might prove to be significant in a larger study popu-
lation.
Since uveitis is a common comorbidity in patients with
JIA, many studies focusing on possible predictors for the
occurrence of uveitis have been performed in the last de-
cades.21 The identification of some predictors led to the
development of a screening protocol for ophthalmologic ex-
amination in patients with JIA in 1993, which was updated
in 2006.14,22 ANApositivity, oligoarticular JIA, and onset of375ENILE IDIOPATHIC ARTHRITIS
FIGURE 2. The area under the curve shows the ability of the
prediction model to predict the development of uveitis in pa-
tients with juvenile idiopathic arthritis. The closer the area un-
der the (receiver operating characteristic) curve (AUC) comes
to 1, the more accurate is the prediction model. The diagonal
line with interruption (AUC [ 0.5) represents the situation
in which the model would be useless. The continuous line rep-
resents the AUC for this prediction model (Figure 1), which
is 0.644 (95% confidence interval: 0.582–0.706) after correc-
tion for optimism using the bootstrap procedure.JIA before the age of 7 appeared to be good predictors and
were included in the screening protocols.9,12,14,23 In this
study we have shown that elevated ESR seems to be a
good predictor as well. Therefore we recommend that
ophthalmologists and pediatric rheumatologists be aware
of the increased risk of developing uveitis in children with
the aforementioned risk factors and an additional elevated
ESR at onset of JIA. ESR is already routinely tested in
patients with JIA, so it can easily be implemented in
daily practice. We developed a prediction model for376 AMERICAN JOURNAL OFdevelopment of uveitis that includes ANA, age of onset of
JIA, and ESR.4,14 We validated the model internally with
bootstrapping techniques, but external validation is
required before the model can really be applied. The
proposition of being more aware of high-risk patients in or-
der to protect them from severe complications and visual loss
is in concordance with the ideas of Chia et al.4,24
In the current study we confirmed the predictive value of
ANA positivity and early age of onset of JIA in univariate
analyses. We could not confirm JIA subtype as a possible
predictor because we only included the subtypes of JIA
that are already proven to be related to the occurrence of
uveitis.
In concordance with previous studies, we did not find a
predictive value of HLA-B27 in our population.12,23
As all other retrospective studies, this study has several
limitations. The study was based on a patient directory
from tertiary centers. So concerning uveitis there might
be a referral bias because there is a possibility that more se-
vere cases are included in the study. This was prevented as
much as possible by requesting information on uveitis sta-
tus via questionnaires to patients and parents who were
screened by ophthalmologists in secondary referral centers,
but it might still cause some referral bias. The case-control
character of this study barely makes it possible to represent
the actual incidence of uveitis in patients with JIA, given
that the ophthalmologic center of the University Medical
Center in Utrecht is a specialized uveitis center with a
high incidence of uveitis patients. We chose a minimum
follow-up with ophthalmologic examinations of 4 years,
but we know that in rare cases uveitis will develop even
up to 20 years after JIA onset. In our study 86% of the pa-
tients with JIA developed uveitis in the first 4 years of
follow-up, which means that some patients in the non-
uveitis group with only 4 years of follow-up might still
develop uveitis in the future.
In conclusion, elevated ESR appears to be a predictor for
the occurrence of uveitis in patients with JIA. Since ESR is
already routinely tested in patients with recently diagnosed
arthritis, its use as a biomarker can easily be implemented
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